1. 'Not of use for much': Hospitals told not to give remdesivir to COVID-19 patients  Sydney Morning Herald
  2. WHO Rejects Remdesivir As Treatment Against COVID-19 In New Guidelines : Goats and Soda  NPR
  3. WHO advises against Remdesivir treatment  FOX 4 Now
  4. Remdesivir’s Failure Is a Warning for Covid-19 Vaccines  Bloomberg
  5. WHO advice on remdesivir is a warning for Covid-19 vaccines  ThePrint
  6. View Full coverage on Google News
The medication was one of the drugs used to treat US President Donald Trump's coronavirus infection.The medication was one of the drugs used to treat US President Donald Trump's coronavirus infection.

The medicine is one of the few to win regulatory approval as a treatment for the disease, but has fallen out of favor with the health authority. The medicine is one of the few to win regulatory approval as a treatment for the disease, but has fallen out of favor with the health authority.

WHO Rejects Remdesivir As Treatment Against COVID-19 In New Guidelines : Goats and Soda : NPR

Health officials around the world are clashing over the use of certain drugs for COVID-19, leading to different treatment options for patients depending on where they live. On Friday, a World Health Organization guidelines panel advised against using the antiviral remdesivir for hospitalized patients, saying there’s no evidence it improves…

Health experts clash over use of certain drugs for COVID-19 - Japan Today

Bloomberg - Are you a robot?

The WHO’s thumbs-down on remdesivir highlights why the FDA has to do more than merely rubber-stamp Covid-19 treatments in the face of heavy White House pressure to move quickly.The WHO’s thumbs-down on remdesivir highlights why the FDA has to do more than merely rubber-stamp Covid-19 treatments in the face of heavy White House pressure to move quickly.

WHO advice on remdesivir is a warning for Covid-19 vaccines

403 Forbidden

A panel of experts said there is currently “no evidence” that the antiviral drug improves survival rates or shortens recovery time.A panel of experts said there is currently “no evidence” that the antiviral drug improves survival rates or shortens recovery time.

WHO advises against use of remdesivir to treat hospitalized COVID-19 patients | TheHill

A panel of experts said there is currently “no evidence” that the antiviral drug improves survival rates or shortens recovery time.A panel of experts said there is currently “no evidence” that the antiviral drug improves survival rates or shortens recovery time.

WHO advises against use of remdesivir to treat hospitalized COVID-19 patients | TheHill

The World Health Organization on Thursday recommended against continuing to use the antiviral remdesivir to treat COVID-19.The World Health Organization on Thursday recommended against continuing to use the antiviral remdesivir to treat COVID-19.

Remdesivir, hailed — and taken — by Trump, doesn't work for coronavirus, World Health Organization declares

Gilead Sciences’ Veklury, better known as remdesivir, is so far the only COVID-19 therapy officially approved by the FDA, but the World Health Organization has some other ideas about the drug’s worth. Guideline development experts at the international body have recommended against the drug's use in any hospitalized patients.Gilead Sciences’ Veklury, better known as remdesivir, is so far the only COVID-19 therapy officially approved by the FDA, but the World Health Organization has some other ideas about the drug’s worth. Guideline development experts at the international body have recommended against the drug's use in any hospitalized patients.

Gilead gets WHO cold shoulder for remdesivir in COVID-19, launches speedy defense | FiercePharma

UN organization claims the medicine, which has received approval as a coronavirus treatment from several health agencies, has 'no important effect' on improving survival chancesUN organization claims the medicine, which has received approval as a coronavirus treatment from several health agencies, has 'no important effect' on improving survival chances

WHO advises against using drug remdesivir for treating COVID patients | The Times of Israel

WHO has issued a conditional recommendation against the use of remdesivir in hospitalized patients, regardless of disease severity, as there is currently no evidence that remdesivir improves survival and other outcomes in these patients. This recommendation, released on 20 November, is part of a living guideline on clinical care for COVID-19.

WHO Warns About the Use of Remdesivir in COVID-19 Patients, Has Little or No Effect - Novinite.com - Sofia News Agency

An advisory body of the UN health agency is not recommending the use of the high-profile antiviral drug Remdesivir for hospitalized COVID-19 patients, saying on Thursday there is insufficient evidence that it improves survival outcomes or cuts down on the need for patients to be put onto ventilators.  |An advisory body of the UN health agency is not recommending the use of the high-profile antiviral drug Remdesivir for hospitalized COVID-19 patients, saying on Thursday there is insufficient

Remdesivir no COVID-19 silver bullet, says UN health agency | | UN News

A Guideline Development Group of the World Health Organization is not recommending the use of antiviral drug Remdesivir for hospitalized COVID-19 patients.A Guideline Development Group of the World Health Organization is not recommending the use of antiviral drug Remdesivir for hospitalized COVID-19 patients.

WHO warns against Remdesivir use for COVID treatment, says 'possibility of harm remains'

Health Secretary Matt Hancock also praised remdesivir when it was approved for use in the UK back in May.Health Secretary Matt Hancock also praised remdesivir when it was approved for use in the UK back in May.

COVID-19: World Health Organization advises against drug Donald Trump took to treat coronavirus | World News | Sky News

The World Health Organisation has recommended against using the antiviral drug remdesivir to treat Covid-19, in a blow to US manufacturer Gilead Sciences. The World Health Organisation has recommended against using the antiviral drug remdesivir to treat Covid-19, in a blow to US manufacturer Gilead Sciences. 

WHO advises against antiviral drug remdesivir to treat Covid-19

The antiviral drug remdesivir is not suggested for patients admitted to hospital with COVID-19, regardless of how severely ill they are, because there is currently no evidence that it improves survival ...

WHO Guideline Development Group advises against use of remdesivir for COVID-19

Expert WHO panel finds ‘no evidence’ that antiviral drug improves patient outcomesExpert WHO panel finds ‘no evidence’ that antiviral drug improves patient outcomes

WHO group recommends against use of remdesivir drug for Covid-19

The World Health Organization is recommending against the use of the antiviral remdesivir (Veklury, Gilead) for the treatment of COVID-19.
 

WHO backs off on remdesivir as FDA issues another EUA | RAPS

A World Health Organization panel advised doctors Thursday against using Gilead Sciences antiviral drug remdesivir as a treatment for p...A World Health Organization panel advised doctors Thursday against using Gilead Sciences antiviral drug remdesivir as a treatment for patients hospitalized with the coronavrus disease, saying the...

Gilead Sciences drug remdesivir used in 50 countries for virus rejected by WHO | The Standard

UK News: LONDON: Gilead's drug remdesivir is not recommended for patients hospitalised with Covid-19, regardless of how ill they are, as there is no evidence i.UK News: LONDON: Gilead's drug remdesivir is not recommended for patients hospitalised with Covid-19, regardless of how ill they are, as there is no evidence i.

Remdesivir Vaccine News: WHO advises against Gilead's remdesivir for all hospitalised Covid-19 patients | World News - Times of India

A World Health Organization panel said the anti-viral drug remdesivir should not be used to treat COVID-19 patients, no matter how ill they are. The experts said the drug has "no important effect" on death rates.A World Health Organization panel said the anti-viral drug remdesivir should not be used to treat COVID-19 patients, no matter how ill they are. The experts said the drug has "no important effect" on death rates.

Coronavirus: WHO advises against remdesivir for hospitalized COVID-19 patients | News | DW | 20.11.2020

Health officials around the world are clashing over the use of certain drugs for COVID-19, leading to different treatment options for patients depending on where they live.Health officials around the world are clashing over the use of certain drugs for COVID-19, leading to different treatment options for patients depending on where they live.

WHO’s take on remdesivir leads to more confusion over coronavirus drugs - National | Globalnews.ca

LONDON (Reuters) -- Gilead's drug remdesivir is not recommended for patients hospitalised with COVID-19, regardless of how ill they are, as there is nLarge trial shows no evidence the US company's drug improves survival, panel says

WHO advises not to give Gilead's remdesivir to COVID patients - Nikkei Asia

Speed is prized in the race to beat back Covid-19 — as it should be. But the WHO’s thumbs-down on remdesivir is also a reminder that hasty drug development and approval is risky.Speed is prized in the race to beat back Covid-19 — as it should be. But the WHO’s thumbs-down on remdesivir is also a reminder that hasty drug development and approval is risky.

Coronavirus: Remdesivir’s failure is a warning for Covid-19 vaccines - health - Hindustan Times

A World Health Organization panel said on Friday there is no evidence Gilead’s remdesivir improves survival or reduces the need for ventilation and did not recommend the drug for all patients hospitalized with Covid-19.A World Health Organization panel said on Friday there is no evidence Gilead’s remdesivir improves survival or reduces the need for ventilation and did not recommend the drug for all patients hospitalized with Covid-19.

WHO panel advises against Gilead’s remdesivir for patients hospitalized with Covid-19 — RT World News

Access Denied

The move comes over a month after WHO’s 'Solidarity Trial' found the anti-viral showed no evidence of impact on mortality, faster clinical improvement or other outcomes. In Mumbai, however, doctors plan to continue its use for now.The move comes over a month after WHO’s 'Solidarity Trial' found the anti-viral showed no evidence of impact on mortality, faster clinical improvement or other outcomes. In Mumbai, however, doctors plan to continue its use for now.

As WHO advises against Remdesivir use, Mumbai doctors plan to stick to it | Cities News,The Indian Express

This guidance comes less than 24 hours after FDA grants an EUA for its use combined with baricitinib.This guidance comes less than 24 hours after FDA grants an EUA for its use combined with baricitinib.

WHO Recommends Against Remdesivir in Hospitalized Patients | Contagion Live

Global health agency says there is no evidence that drug improves survival rates or reduces need for ventilation.Global health agency says there is no evidence that drug improves survival rates or reduces need for ventilation.

search

The World Health Organization has advised against administering the antiviral drug remdesivir to hospitalized coronavirus patients, regardless of how ill they are.The World Health Organization has advised against administering the antiviral drug remdesivir to hospitalized coronavirus patients, regardless of how ill they are.

WHO: Remdesivir not recommended for COVID-19 | NHK WORLD-JAPAN News

In the new assessment, the WHO panel of experts analyzed data from four international randomized trials that assessed several treatments for COVID-19 and included more than 7,000 hospitalized COVID-19 patients. In the new assessment, the WHO panel of experts analyzed data from four international randomized trials that assessed several treatments for COVID-19 and included more than 7,000 hospitalized COVID-19 patients.

WHO Says No to Remdesivir as COVID-19 Treatment - WebMD

The World Health Organization (WHO) has advised against using Gilead’s remdesivir in patients hospitalized with coronavirus, weeks after the drug was shown to have “little or no effect” during the agency’s multicountry Solidarity Trial.The World Health Organization (WHO) has advised against using Gilead’s remdesivir in patients hospitalized with coronavirus, weeks after the drug was shown to have “little or no effect” during the agency’s multicountry Solidarity Trial.

The agency concluded there's no evidence that the drug improves survival or positively impacts other outcomes.The agency concluded there's no evidence that the drug improves survival or positively impacts other outcomes.

WHO Recommends Against Using Gilead's Remdesivir for COVID-19 | The Motley Fool

WHO Friday advised against use of remdesivir for Covid because there’s ‘no evidence’ it improves survival, but doctors say it works on moderately ill patients.

Delhi doctors unlikely to follow new WHO advice, say remdesivir works in moderate Covid cases – ThePrint

403 Forbidden

Gilead's remdesivir should not be used for patients hospitalised with COVID-19, regardless of how ill they are, as there is no evidence the drug improves survival or reduces the need for ventilation, a World Health Organization panel said on Friday. "The ... panel found a lack of evidence that remdesivir improved outcomes that matter to patients," the guideline said. "Especially given the costs and resource implications associated with remdesivir ... the panel felt the responsibility should be on demonstrating evidence of efficacy, which is not established by the currently available data," it added.Gilead's remdesivir should not be used for patients hospitalised with COVID-19, regardless of how ill they are, as there is no evidence the drug improves survival or reduces the need for ventilation, a World Health Organization panel said on Friday. "The ... panel found a lack of evidence that remdesivir improved outcomes that matter to patients," the guideline said. "Especially given the costs and resource implications associated with remdesivir ... the panel felt the responsibility should be on demonstrating evidence of efficacy, which is not established by the currently available data," it added.

Don't use Gilead's remdesivir in hospitalized COVID-19 patients, WHO says

The drug is given intravenously, costly and complex to administer, the panel concluded that it has no meaningful effect on death rates or other important outcomes for patients.The drug is given intravenously, costly and complex to administer, the panel concluded that it has no meaningful effect on death rates or other important outcomes for patients.

WHO urges against remdesivir for COVID-19 as health experts clash on its effectiveness - Health News , Firstpost

A World Health Organization (WHO) panel recommended against using remdesivir in hospitalized patients with COVID-19 because there is no evidence it improves survival.A World Health Organization (WHO) panel recommended against using remdesivir in hospitalized patients with COVID-19 because there is no evidence it improves survival.

WHO panel recommends against use of remdesivir for COVID-19 patients | TheHill

A World Health Organization (WHO) panel recommended against using remdesivir in hospitalized patients with COVID-19 because there is no evidence it improves survival.A World Health Organization (WHO) panel recommended against using remdesivir in hospitalized patients with COVID-19 because there is no evidence it improves survival.

WHO panel recommends against use of remdesivir for COVID-19 patients | TheHill

In a statement released on Thursday, the WHO said that its Guideline Committee recommends the use of Remdesivir should be discontinued in hospitals.In a statement released on Thursday, the WHO said that its Guideline Committee recommends the use of Remdesivir should be discontinued in hospitals.

WHO Asks Countries To Stop The Use of Remdesivir In Treatment of COVID-19 Patients | HW English